Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00453700 · ClinicalTrials.gov registry record

Prevalence of Chagas Disease in Immigrant Patients With Conduction Abnormalities on Electrocardiogram

A clinical trial, sponsored by Olive View-UCLA Education & Research Institute.

Completed
Registry status
327
Enrollment target

NCT00453700: Completed study, sponsored by Olive View-UCLA Education & Research Institute.

NCT00453700 is a clinical trial that has completed, run by Olive View-UCLA Education & Research Institute. The registered enrollment target is 327 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00453700 has completed, sponsored by Olive View-UCLA Education & Research Institute.

COMPLETED
Registry status
327 participants
Enrollment target

Study Summary

Chagas disease is endemic to the Americas, infecting between 16-18 million individuals. In immigrant populations in the United States from endemic areas, it is estimated up to 4.9% may be asymptomatic carriers of Trypanosoma cruzi, the organism which causes Chagas disease. Between 10-20% of these patients progress to development of end-stage cardiomyopathy with a high associated morbidity. Following acute disease, patients enter into an indeterminate phase which can last 10-20 years. The earliest sign of cardiac involvement usually is electrocardiogram abnormalities. The most common abnormality is right bundle branch block (RBBB), followed by left anterior fascicular block (LAFB), and left bundle branch block (LBBB). Recent studies have shown that treatment of patients at this stage with antiparasitics may delay the progression of overt cardiomyopathy. At the University of California, Los Angeles, there is a large population of immigrant patients from countries endemic to Chagas disease. The researchers propose that screening patients with conduction abnormalities on electrocardiogram may be a potentially useful method to identify patients with early cardiac manifestations of Chagas disease. The researchers hope to enroll approximately 300 individuals with RBBB, LAFB or LBBB on electrocardiogram to determine the incidence of Chagas disease in this patient population.

Interventions

  • PROCEDURE Trypanosoma cruzi serology

Trial Details

FieldValue
Enrollment Target 327 participants
Start Date 2007-01
Est. Completion 2010-12

What the finished NCT00453700 record still lists

NCT00453700 is an observational study that tracks outcomes without assigning an intervention. The registered 327 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Trypanosoma cruzi serology is the first listed.

NCT00453700 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00453700 about?

NCT00453700 is a clinical study titled "Prevalence of Chagas Disease in Immigrant Patients With Conduction Abnormalities on Electrocardiogram". Chagas disease is endemic to the Americas, infecting between 16-18 million individuals. In immigrant populations in the United States from endemic areas, it is estimated up to 4.9% may be asymptomatic carriers of Trypanosoma cruzi, the organism which causes Chagas disease. Between 10-20% of these pa...

What is the current status of trial NCT00453700?

This trial is currently completed. The enrollment target is 327 participants. The study started on 2007-01. Estimated completion is 2010-12.

What interventions are being tested in trial NCT00453700?

The interventions under investigation include: Trypanosoma cruzi serology (PROCEDURE).

Who is sponsoring clinical trial NCT00453700?

This trial is sponsored by Olive View-UCLA Education & Research Institute, which has 11 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04486378 · 327 participants · Phase 2

    A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

  • NCT06370182 · 327 participants · NA

    Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter

  • NCT05156983 · 328 participants · Phase 3

    A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

  • NCT05380401 · 328 participants · NA

    Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00453700, the US trial registry maintained by the National Library of Medicine. NCT00453700 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.